

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | presynaptic membrane assembly (GO:0097105) | 4.79789195 |
| 2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.65286366 |
| 3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.65286366 |
| 4 | modulation by symbiont of host immune response (GO:0052553) | 4.65286366 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.65286366 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.65286366 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.65286366 |
| 8 | neuronal stem cell maintenance (GO:0097150) | 4.57060631 |
| 9 | lateral sprouting from an epithelium (GO:0060601) | 4.52829597 |
| 10 | pattern specification involved in kidney development (GO:0061004) | 4.50528783 |
| 11 | presynaptic membrane organization (GO:0097090) | 4.42304130 |
| 12 | postsynaptic membrane organization (GO:0001941) | 4.34929017 |
| 13 | central nervous system myelination (GO:0022010) | 4.33985729 |
| 14 | axon ensheathment in central nervous system (GO:0032291) | 4.33985729 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 4.33863347 |
| 16 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.27436916 |
| 17 | axonal fasciculation (GO:0007413) | 4.06022085 |
| 18 | microglial cell activation (GO:0001774) | 4.03956866 |
| 19 | heart valve formation (GO:0003188) | 3.96990255 |
| 20 | nucleobase catabolic process (GO:0046113) | 3.84078777 |
| 21 | neuron recognition (GO:0008038) | 3.82210125 |
| 22 | layer formation in cerebral cortex (GO:0021819) | 3.81871074 |
| 23 | axonemal dynein complex assembly (GO:0070286) | 3.81761510 |
| 24 | negative regulation of cell killing (GO:0031342) | 3.74182937 |
| 25 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.74182937 |
| 26 | vocalization behavior (GO:0071625) | 3.68626552 |
| 27 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.62605204 |
| 28 | limb bud formation (GO:0060174) | 3.60146610 |
| 29 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.60117152 |
| 30 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.58980946 |
| 31 | camera-type eye morphogenesis (GO:0048593) | 3.56010549 |
| 32 | apical protein localization (GO:0045176) | 3.53030809 |
| 33 | somite development (GO:0061053) | 3.50266379 |
| 34 | establishment of planar polarity (GO:0001736) | 3.35230998 |
| 35 | establishment of tissue polarity (GO:0007164) | 3.35230998 |
| 36 | neuron fate determination (GO:0048664) | 3.33123989 |
| 37 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 3.31611470 |
| 38 | germ cell migration (GO:0008354) | 3.31590592 |
| 39 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.30637332 |
| 40 | cilium movement (GO:0003341) | 3.29959899 |
| 41 | negative regulation of astrocyte differentiation (GO:0048712) | 3.28864684 |
| 42 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.28274083 |
| 43 | tongue development (GO:0043586) | 3.25658582 |
| 44 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.22840620 |
| 45 | asymmetric protein localization (GO:0008105) | 3.21860887 |
| 46 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.20542127 |
| 47 | auditory behavior (GO:0031223) | 3.20187362 |
| 48 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.19226219 |
| 49 | clathrin coat assembly (GO:0048268) | 3.17508910 |
| 50 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.17287193 |
| 51 | glomerulus development (GO:0032835) | 3.16508194 |
| 52 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.15832220 |
| 53 | response to host immune response (GO:0052572) | 3.15832220 |
| 54 | radial glial cell differentiation (GO:0060019) | 3.14386551 |
| 55 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 3.14030496 |
| 56 | axon extension involved in axon guidance (GO:0048846) | 3.14030496 |
| 57 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.09686371 |
| 58 | response to host (GO:0075136) | 3.09686371 |
| 59 | response to host defenses (GO:0052200) | 3.09686371 |
| 60 | neuron cell-cell adhesion (GO:0007158) | 3.08280536 |
| 61 | notochord development (GO:0030903) | 3.03771143 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.01730473 |
| 63 | positive regulation of mast cell degranulation (GO:0043306) | 3.01730473 |
| 64 | macrophage activation (GO:0042116) | 2.99176502 |
| 65 | synaptic vesicle maturation (GO:0016188) | 2.98146794 |
| 66 | response to auditory stimulus (GO:0010996) | 2.97361401 |
| 67 | locomotory exploration behavior (GO:0035641) | 2.97310874 |
| 68 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.96424888 |
| 69 | semaphorin-plexin signaling pathway (GO:0071526) | 2.96316463 |
| 70 | cochlea development (GO:0090102) | 2.94618539 |
| 71 | negative regulation of glial cell differentiation (GO:0045686) | 2.91508961 |
| 72 | retinal ganglion cell axon guidance (GO:0031290) | 2.91084015 |
| 73 | proline transport (GO:0015824) | 2.89889093 |
| 74 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.89411125 |
| 75 | ephrin receptor signaling pathway (GO:0048013) | 2.89229254 |
| 76 | lens fiber cell development (GO:0070307) | 2.88294561 |
| 77 | neutrophil mediated immunity (GO:0002446) | 2.83638084 |
| 78 | positive regulation of synapse assembly (GO:0051965) | 2.82236468 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 2.82139309 |
| 80 | otic vesicle formation (GO:0030916) | 2.80807038 |
| 81 | cell-cell junction maintenance (GO:0045217) | 2.80313281 |
| 82 | neutrophil activation involved in immune response (GO:0002283) | 2.79218259 |
| 83 | regulation of leukocyte degranulation (GO:0043300) | 2.79051502 |
| 84 | epithelial cilium movement (GO:0003351) | 2.78822092 |
| 85 | positive regulation of leukocyte degranulation (GO:0043302) | 2.77944998 |
| 86 | dendrite morphogenesis (GO:0048813) | 2.77894946 |
| 87 | segment specification (GO:0007379) | 2.75625310 |
| 88 | response to peptidoglycan (GO:0032494) | 2.75417017 |
| 89 | cellular response to cholesterol (GO:0071397) | 2.72964413 |
| 90 | convergent extension (GO:0060026) | 2.72518872 |
| 91 | Notch signaling involved in heart development (GO:0061314) | 2.72455610 |
| 92 | I-kappaB phosphorylation (GO:0007252) | 2.71382793 |
| 93 | regulation of inclusion body assembly (GO:0090083) | 2.70981254 |
| 94 | cell proliferation involved in metanephros development (GO:0072203) | 2.68167453 |
| 95 | neutrophil chemotaxis (GO:0030593) | 2.68165691 |
| 96 | negative regulation of smoothened signaling pathway (GO:0045879) | 2.67226137 |
| 97 | mechanosensory behavior (GO:0007638) | 2.66256618 |
| 98 | respiratory burst (GO:0045730) | 2.66245923 |
| 99 | skeletal muscle organ development (GO:0060538) | 2.65679682 |
| 100 | membrane assembly (GO:0071709) | 2.64885308 |
| 101 | alanine transport (GO:0032328) | 2.64225439 |
| 102 | renal system development (GO:0072001) | 2.64169887 |
| 103 | axon extension (GO:0048675) | 2.64157031 |
| 104 | cGMP-mediated signaling (GO:0019934) | 2.63906097 |
| 105 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.63615774 |
| 106 | regulation of synapse structural plasticity (GO:0051823) | 2.63512681 |
| 107 | regulation of mast cell degranulation (GO:0043304) | 2.62860793 |
| 108 | Wnt signaling pathway, planar cell polarity pathway (GO:0060071) | 2.62790291 |
| 109 | cell adhesion mediated by integrin (GO:0033627) | 2.62550609 |
| 110 | non-canonical Wnt signaling pathway (GO:0035567) | 2.61139683 |
| 111 | neutrophil migration (GO:1990266) | 2.60676302 |
| 112 | post-anal tail morphogenesis (GO:0036342) | 2.60328693 |
| 113 | central nervous system neuron axonogenesis (GO:0021955) | 2.59839803 |
| 114 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.58795684 |
| 115 | cell proliferation in forebrain (GO:0021846) | 2.58391014 |
| 116 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.58285059 |
| 117 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.57102244 |
| 118 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.57102244 |
| 119 | apoptotic cell clearance (GO:0043277) | 2.57043754 |
| 120 | establishment of nucleus localization (GO:0040023) | 2.57035983 |
| 121 | regulation of astrocyte differentiation (GO:0048710) | 2.56646252 |
| 122 | negative regulation of inclusion body assembly (GO:0090084) | 2.55952275 |
| 123 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.55917591 |
| 124 | macroautophagy (GO:0016236) | 2.54784844 |
| 125 | cerebellar granule cell differentiation (GO:0021707) | 2.54574962 |
| 126 | digestive tract morphogenesis (GO:0048546) | 2.54328661 |
| 127 | regulation of ARF protein signal transduction (GO:0032012) | 2.52985397 |
| 128 | regulation of regulated secretory pathway (GO:1903305) | 2.51845839 |
| 129 | forebrain neuron differentiation (GO:0021879) | 2.51759309 |
| 130 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.51750627 |
| 131 | oligodendrocyte differentiation (GO:0048709) | 2.51056935 |
| 132 | establishment or maintenance of apical/basal cell polarity (GO:0035088) | 2.50753803 |
| 133 | establishment or maintenance of bipolar cell polarity (GO:0061245) | 2.50753803 |
| 134 | limb development (GO:0060173) | 2.49855694 |
| 135 | appendage development (GO:0048736) | 2.49855694 |
| 136 | positive regulation of vascular permeability (GO:0043117) | 2.48496560 |
| 137 | ethanol oxidation (GO:0006069) | 2.48024798 |
| 138 | regulation of establishment of planar polarity (GO:0090175) | 2.47671365 |
| 139 | myeloid cell activation involved in immune response (GO:0002275) | 2.47101293 |
| 140 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.46629771 |
| 141 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.46358077 |
| 142 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199 | 2.46178818 |
| 143 | ear development (GO:0043583) | 2.45948133 |
| 144 | establishment of mitochondrion localization (GO:0051654) | 2.45898540 |
| 145 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.44880657 |
| 146 | receptor catabolic process (GO:0032801) | 2.44686329 |
| 147 | regulation of oligodendrocyte differentiation (GO:0048713) | 2.44681536 |
| 148 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.44509273 |
| 149 | lens morphogenesis in camera-type eye (GO:0002089) | 2.43765413 |
| 150 | hindbrain development (GO:0030902) | 2.43741162 |
| 151 | cell differentiation involved in kidney development (GO:0061005) | 2.42542882 |
| 152 | epithelial tube branching involved in lung morphogenesis (GO:0060441) | 2.41931032 |
| 153 | cranial nerve development (GO:0021545) | 2.41221542 |
| 154 | prepulse inhibition (GO:0060134) | 2.41002775 |
| 155 | positive regulation of axon extension (GO:0045773) | 2.37365312 |
| 156 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.37075500 |
| 157 | cellular extravasation (GO:0045123) | 2.35945881 |
| 158 | cortical actin cytoskeleton organization (GO:0030866) | 2.35589993 |
| 159 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.35453713 |
| 160 | neuron projection extension (GO:1990138) | 2.34911638 |
| 161 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.34786829 |
| 162 | positive regulation of macrophage cytokine production (GO:0060907) | 2.34748946 |
| 163 | regulation of ARF GTPase activity (GO:0032312) | 2.34390965 |
| 164 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.33649893 |
| 165 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.31925802 |
| 166 | negative regulation of granulocyte differentiation (GO:0030853) | 2.31834272 |
| 167 | response to muramyl dipeptide (GO:0032495) | 2.30656223 |
| 168 | positive regulation of heat generation (GO:0031652) | 2.29247870 |
| 169 | regulation of cholesterol storage (GO:0010885) | 2.26928723 |
| 170 | exploration behavior (GO:0035640) | 2.25291812 |
| 171 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.25105356 |
| 172 | tolerance induction (GO:0002507) | 2.22569762 |
| 173 | leukocyte aggregation (GO:0070486) | 2.22273537 |
| 174 | granulocyte chemotaxis (GO:0071621) | 2.21214442 |
| 175 | chondroitin sulfate catabolic process (GO:0030207) | 2.21156878 |
| 176 | granulocyte activation (GO:0036230) | 2.17887391 |
| 177 | response to fungus (GO:0009620) | 2.17848097 |
| 178 | myeloid leukocyte mediated immunity (GO:0002444) | 2.17590982 |
| 179 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.17335606 |
| 180 | glutamate secretion (GO:0014047) | 2.17158756 |
| 181 | positive regulation of filopodium assembly (GO:0051491) | 2.17129239 |
| 182 | low-density lipoprotein particle clearance (GO:0034383) | 2.15446381 |
| 183 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.15347082 |
| 184 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.15092741 |
| 185 | granulocyte migration (GO:0097530) | 2.14695719 |
| 186 | response to cholesterol (GO:0070723) | 2.14618104 |
| 187 | nerve growth factor signaling pathway (GO:0038180) | 2.14616994 |
| 188 | cell migration in hindbrain (GO:0021535) | 2.14091151 |
| 189 | dendritic spine morphogenesis (GO:0060997) | 2.13604909 |
| 190 | heparan sulfate proteoglycan metabolic process (GO:0030201) | 2.13062890 |
| 191 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.12829480 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.23683422 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.13274116 |
| 3 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.97707044 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.87887342 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.81131120 |
| 6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53478864 |
| 7 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.44739395 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.40800171 |
| 9 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.38249707 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.28310234 |
| 11 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24774828 |
| 12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10776639 |
| 13 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10463398 |
| 14 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.09765936 |
| 15 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07605834 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.01303784 |
| 17 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.99122115 |
| 18 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91876784 |
| 19 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.87156694 |
| 20 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.86839373 |
| 21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.82865788 |
| 22 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.78680653 |
| 23 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.75094668 |
| 24 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.71007980 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.69775593 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.69281313 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.68157486 |
| 28 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.64262305 |
| 29 | SPI1_23127762_ChIP-Seq_K562_Human | 1.63883458 |
| 30 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.63873832 |
| 31 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.63381913 |
| 32 | KDM2B_26808549_Chip-Seq_K562_Human | 1.62917338 |
| 33 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60408720 |
| 34 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.59788427 |
| 35 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.58607130 |
| 36 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.58387766 |
| 37 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.57083941 |
| 38 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.56691168 |
| 39 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.55150518 |
| 40 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.53388595 |
| 41 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.52047226 |
| 42 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.51347195 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49276936 |
| 44 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.49054542 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.48971800 |
| 46 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.45834527 |
| 47 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45597161 |
| 48 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.43726638 |
| 49 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.43013023 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.41679120 |
| 51 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.41266640 |
| 52 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.41148447 |
| 53 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.40812895 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.40198683 |
| 55 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38957050 |
| 56 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.38609506 |
| 57 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.37646110 |
| 58 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.37606818 |
| 59 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.37539383 |
| 60 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34997865 |
| 61 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.33905782 |
| 62 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.33845227 |
| 63 | * CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.33436314 |
| 64 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.32498360 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.31461179 |
| 66 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31040629 |
| 67 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.30695438 |
| 68 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.30486070 |
| 69 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.29961863 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29918504 |
| 71 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.27982369 |
| 72 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.27867660 |
| 73 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.27670446 |
| 74 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.27623503 |
| 75 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26728725 |
| 76 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.25405153 |
| 77 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.25355545 |
| 78 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25355545 |
| 79 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.23925606 |
| 80 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.23197664 |
| 81 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.22762438 |
| 82 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22619121 |
| 83 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.22529238 |
| 84 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.22045554 |
| 85 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.21960060 |
| 86 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.21431427 |
| 87 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.21354060 |
| 88 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.20046717 |
| 89 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.20046717 |
| 90 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.19963170 |
| 91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.19742160 |
| 92 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.19506930 |
| 93 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.19422484 |
| 94 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19105927 |
| 95 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18605048 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.18375383 |
| 97 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.17856338 |
| 98 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15987340 |
| 99 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.13918058 |
| 100 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12566539 |
| 101 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11711846 |
| 102 | TP53_16413492_ChIP-PET_HCT116_Human | 1.10515436 |
| 103 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10314530 |
| 104 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10139036 |
| 105 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.09945572 |
| 106 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.09102881 |
| 107 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08380371 |
| 108 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.08208615 |
| 109 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07981853 |
| 110 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.07094528 |
| 111 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.06135188 |
| 112 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05762738 |
| 113 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05468273 |
| 114 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04835681 |
| 115 | MYC_22102868_ChIP-Seq_BL_Human | 1.04525893 |
| 116 | * RNF2_27304074_Chip-Seq_NSC_Mouse | 1.04248280 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.03361464 |
| 118 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.02975477 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.02660656 |
| 120 | POU5F1_18347094_ChIP-ChIP_MESCs_Mouse | 1.01581766 |
| 121 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.00978368 |
| 122 | AR_19668381_ChIP-Seq_PC3_Human | 1.00728651 |
| 123 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.00504952 |
| 124 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00257171 |
| 125 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.99717732 |
| 126 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99681620 |
| 127 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99578327 |
| 128 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.99473492 |
| 129 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.99219406 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98862669 |
| 131 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.98547683 |
| 132 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.98213512 |
| 133 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97743489 |
| 134 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 0.97338657 |
| 135 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96927447 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96615380 |
| 137 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.96596934 |
| 138 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.94096198 |
| 139 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.93899931 |
| 140 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.93704757 |
| 141 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.93232484 |
| 142 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 0.93152268 |
| 143 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.93013450 |
| 144 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.92878098 |
| 145 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.92542662 |
| 146 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.91510115 |
| 147 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.91476420 |
| 148 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.91192435 |
| 149 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.88568859 |
| 150 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88343520 |
| 151 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.88338828 |
| 152 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88322299 |
| 153 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.88102340 |
| 154 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.87410798 |
| 155 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.86673713 |
| 156 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86582778 |
| 157 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86084676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000566_synostosis | 5.20540027 |
| 2 | MP0003303_peritoneal_inflammation | 4.94911543 |
| 3 | MP0003136_yellow_coat_color | 4.86915565 |
| 4 | MP0000569_abnormal_digit_pigmentation | 4.48658520 |
| 5 | MP0004859_abnormal_synaptic_plasticity | 3.63252274 |
| 6 | MP0003172_abnormal_lysosome_physiology | 3.48769040 |
| 7 | MP0004858_abnormal_nervous_system | 3.27271246 |
| 8 | MP0002653_abnormal_ependyma_morphology | 2.96251214 |
| 9 | MP0009379_abnormal_foot_pigmentation | 2.88546741 |
| 10 | MP0005058_abnormal_lysosome_morphology | 2.71490761 |
| 11 | MP0005076_abnormal_cell_differentiation | 2.71143343 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.67183449 |
| 13 | MP0003880_abnormal_central_pattern | 2.61213075 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.50416265 |
| 15 | MP0000604_amyloidosis | 2.43513367 |
| 16 | MP0003436_decreased_susceptibility_to | 2.40169516 |
| 17 | MP0003075_altered_response_to | 2.34769669 |
| 18 | MP0009278_abnormal_bone_marrow | 2.26187229 |
| 19 | MP0006082_CNS_inflammation | 2.21632818 |
| 20 | MP0002419_abnormal_innate_immunity | 2.20578174 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.19686428 |
| 22 | MP0009780_abnormal_chondrocyte_physiolo | 2.17641972 |
| 23 | MP0003938_abnormal_ear_development | 2.10882718 |
| 24 | MP0004510_myositis | 2.08966498 |
| 25 | MP0005248_abnormal_Harderian_gland | 2.06716316 |
| 26 | MP0003690_abnormal_glial_cell | 2.05418292 |
| 27 | MP0002249_abnormal_larynx_morphology | 2.03551116 |
| 28 | MP0000537_abnormal_urethra_morphology | 1.97258516 |
| 29 | MP0005167_abnormal_blood-brain_barrier | 1.91714694 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.91064760 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.88669459 |
| 32 | MP0003329_amyloid_beta_deposits | 1.85309510 |
| 33 | MP0003122_maternal_imprinting | 1.85090428 |
| 34 | MP0005377_hearing/vestibular/ear_phenot | 1.85004664 |
| 35 | MP0003878_abnormal_ear_physiology | 1.85004664 |
| 36 | MP0010030_abnormal_orbit_morphology | 1.79484931 |
| 37 | MP0000026_abnormal_inner_ear | 1.78856266 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.75688360 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.64974917 |
| 40 | MP0001984_abnormal_olfaction | 1.60525534 |
| 41 | MP0002734_abnormal_mechanical_nocicepti | 1.59517995 |
| 42 | MP0005423_abnormal_somatic_nervous | 1.57047197 |
| 43 | MP0003635_abnormal_synaptic_transmissio | 1.56125730 |
| 44 | MP0008961_abnormal_basal_metabolism | 1.55290397 |
| 45 | MP0002822_catalepsy | 1.54870597 |
| 46 | MP0005499_abnormal_olfactory_system | 1.54070726 |
| 47 | MP0005394_taste/olfaction_phenotype | 1.54070726 |
| 48 | MP0001346_abnormal_lacrimal_gland | 1.49417477 |
| 49 | MP0001485_abnormal_pinna_reflex | 1.49003365 |
| 50 | MP0001299_abnormal_eye_distance/ | 1.47606705 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.47118265 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.46777387 |
| 53 | MP0001293_anophthalmia | 1.44955264 |
| 54 | MP0004130_abnormal_muscle_cell | 1.42289571 |
| 55 | MP0000631_abnormal_neuroendocrine_gland | 1.41795279 |
| 56 | MP0002233_abnormal_nose_morphology | 1.41422725 |
| 57 | MP0003634_abnormal_glial_cell | 1.39654253 |
| 58 | MP0005166_decreased_susceptibility_to | 1.39638549 |
| 59 | MP0004270_analgesia | 1.39476926 |
| 60 | MP0002063_abnormal_learning/memory/cond | 1.38580682 |
| 61 | MP0005000_abnormal_immune_tolerance | 1.36745880 |
| 62 | MP0002152_abnormal_brain_morphology | 1.36348602 |
| 63 | MP0002090_abnormal_vision | 1.35723727 |
| 64 | MP0003861_abnormal_nervous_system | 1.34809587 |
| 65 | MP0001958_emphysema | 1.34744547 |
| 66 | MP0002928_abnormal_bile_duct | 1.34737792 |
| 67 | MP0000778_abnormal_nervous_system | 1.32266669 |
| 68 | MP0002697_abnormal_eye_size | 1.29294745 |
| 69 | MP0002452_abnormal_antigen_presenting | 1.29057069 |
| 70 | MP0008438_abnormal_cutaneous_collagen | 1.28542871 |
| 71 | MP0009053_abnormal_anal_canal | 1.28300806 |
| 72 | MP0001486_abnormal_startle_reflex | 1.28247615 |
| 73 | MP0000343_altered_response_to | 1.27390381 |
| 74 | MP0008789_abnormal_olfactory_epithelium | 1.25310317 |
| 75 | MP0003283_abnormal_digestive_organ | 1.24112390 |
| 76 | MP0005025_abnormal_response_to | 1.24092970 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.23859099 |
| 78 | MP0002092_abnormal_eye_morphology | 1.23760517 |
| 79 | MP0000579_abnormal_nail_morphology | 1.23308004 |
| 80 | MP0003252_abnormal_bile_duct | 1.22797748 |
| 81 | MP0004811_abnormal_neuron_physiology | 1.22464185 |
| 82 | MP0000428_abnormal_craniofacial_morphol | 1.22450341 |
| 83 | MP0001286_abnormal_eye_development | 1.22146057 |
| 84 | MP0002882_abnormal_neuron_morphology | 1.22006712 |
| 85 | MP0004885_abnormal_endolymph | 1.21805138 |
| 86 | MP0003091_abnormal_cell_migration | 1.21558847 |
| 87 | MP0002735_abnormal_chemical_nociception | 1.19818628 |
| 88 | MP0000049_abnormal_middle_ear | 1.19236404 |
| 89 | MP0001502_abnormal_circadian_rhythm | 1.18117705 |
| 90 | MP0004742_abnormal_vestibular_system | 1.17208612 |
| 91 | MP0006292_abnormal_olfactory_placode | 1.14420686 |
| 92 | MP0000383_abnormal_hair_follicle | 1.13984962 |
| 93 | MP0004883_abnormal_blood_vessel | 1.13666518 |
| 94 | MP0005623_abnormal_meninges_morphology | 1.10651939 |
| 95 | MP0009840_abnormal_foam_cell | 1.10555872 |
| 96 | MP0004947_skin_inflammation | 1.09582626 |
| 97 | MP0001529_abnormal_vocalization | 1.08148962 |
| 98 | MP0003633_abnormal_nervous_system | 1.08000540 |
| 99 | MP0003119_abnormal_digestive_system | 1.07817240 |
| 100 | MP0009785_altered_susceptibility_to | 1.07433872 |
| 101 | MP0004133_heterotaxia | 1.06499743 |
| 102 | MP0002282_abnormal_trachea_morphology | 1.05078593 |
| 103 | MP0002064_seizures | 1.04859668 |
| 104 | MP0002184_abnormal_innervation | 1.04540085 |
| 105 | MP0001819_abnormal_immune_cell | 1.02939888 |
| 106 | MP0003448_altered_tumor_morphology | 1.02747179 |
| 107 | MP0003755_abnormal_palate_morphology | 1.02628394 |
| 108 | MP0001845_abnormal_inflammatory_respons | 1.02621360 |
| 109 | MP0001963_abnormal_hearing_physiology | 1.01647131 |
| 110 | MP0002420_abnormal_adaptive_immunity | 0.99170741 |
| 111 | MP0002067_abnormal_sensory_capabilities | 0.98959374 |
| 112 | MP0002723_abnormal_immune_serum | 0.98790416 |
| 113 | MP0000534_abnormal_ureter_morphology | 0.98758847 |
| 114 | MP0001851_eye_inflammation | 0.98244817 |
| 115 | MP0002752_abnormal_somatic_nervous | 0.97575570 |
| 116 | MP0003890_abnormal_embryonic-extraembry | 0.97415364 |
| 117 | MP0002938_white_spotting | 0.96059524 |
| 118 | MP0001970_abnormal_pain_threshold | 0.95873750 |
| 119 | MP0010678_abnormal_skin_adnexa | 0.95856428 |
| 120 | MP0010352_gastrointestinal_tract_polyps | 0.94778225 |
| 121 | MP0001440_abnormal_grooming_behavior | 0.94441924 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.94361271 |
| 123 | MP0002089_abnormal_postnatal_growth/wei | 0.94344422 |
| 124 | MP0003566_abnormal_cell_adhesion | 0.94062466 |
| 125 | MP0002111_abnormal_tail_morphology | 0.93972892 |
| 126 | MP0005257_abnormal_intraocular_pressure | 0.93139396 |
| 127 | MP0005187_abnormal_penis_morphology | 0.92621657 |
| 128 | MP0003942_abnormal_urinary_system | 0.92528041 |
| 129 | MP0003879_abnormal_hair_cell | 0.91568893 |
| 130 | MP0005409_darkened_coat_color | 0.90635432 |
| 131 | MP0010234_abnormal_vibrissa_follicle | 0.90173140 |
| 132 | MP0002116_abnormal_craniofacial_bone | 0.89650193 |
| 133 | MP0001915_intracranial_hemorrhage | 0.89369019 |
| 134 | MP0010307_abnormal_tumor_latency | 0.89121129 |
| 135 | MP0003045_fibrosis | 0.88963525 |
| 136 | MP0000762_abnormal_tongue_morphology | 0.87617771 |
| 137 | MP0002098_abnormal_vibrissa_morphology | 0.87537774 |
| 138 | MP0003453_abnormal_keratinocyte_physiol | 0.85409892 |
| 139 | MP0001177_atelectasis | 0.83839492 |
| 140 | MP0008569_lethality_at_weaning | 0.83457539 |
| 141 | MP0003221_abnormal_cardiomyocyte_apopto | 0.82286467 |
| 142 | MP0002272_abnormal_nervous_system | 0.82088236 |
| 143 | MP0002733_abnormal_thermal_nociception | 0.81501015 |
| 144 | MP0005195_abnormal_posterior_eye | 0.81074776 |
| 145 | MP0001968_abnormal_touch/_nociception | 0.80510925 |
| 146 | MP0001800_abnormal_humoral_immune | 0.80326359 |
| 147 | MP0005666_abnormal_adipose_tissue | 0.79599395 |
| 148 | MP0003937_abnormal_limbs/digits/tail_de | 0.78870766 |
| 149 | MP0003631_nervous_system_phenotype | 0.78536611 |
| 150 | MP0005391_vision/eye_phenotype | 0.78264137 |
| 151 | MP0002081_perinatal_lethality | 0.77980125 |
| 152 | MP0008004_abnormal_stomach_pH | 0.77861738 |
| 153 | MP0008469_abnormal_protein_level | 0.76709649 |
| 154 | MP0005164_abnormal_response_to | 0.75971861 |
| 155 | MP0009764_decreased_sensitivity_to | 0.75907614 |
| 156 | MP0002405_respiratory_system_inflammati | 0.75244782 |
| 157 | MP0009046_muscle_twitch | 0.74251815 |
| 158 | MP0005671_abnormal_response_to | 0.72845673 |
| 159 | MP0002909_abnormal_adrenal_gland | 0.72702829 |
| 160 | MP0000733_abnormal_muscle_development | 0.72484881 |
| 161 | MP0000249_abnormal_blood_vessel | 0.71637466 |
| 162 | MP0002572_abnormal_emotion/affect_behav | 0.70731782 |
| 163 | MP0009745_abnormal_behavioral_response | 0.70572780 |
| 164 | MP0005390_skeleton_phenotype | 0.70548113 |
| 165 | MP0005397_hematopoietic_system_phenotyp | 0.70433322 |
| 166 | MP0001545_abnormal_hematopoietic_system | 0.70433322 |
| 167 | MP0002896_abnormal_bone_mineralization | 0.69981867 |
| 168 | MP0000955_abnormal_spinal_cord | 0.68741580 |
| 169 | MP0001790_abnormal_immune_system | 0.67989556 |
| 170 | MP0005387_immune_system_phenotype | 0.67989556 |
| 171 | MP0000858_altered_metastatic_potential | 0.67881167 |
| 172 | MP0002736_abnormal_nociception_after | 0.66876216 |
| 173 | MP0005174_abnormal_tail_pigmentation | 0.66677641 |
| 174 | MP0001663_abnormal_digestive_system | 0.66470357 |
| 175 | MP0003724_increased_susceptibility_to | 0.66182652 |
| 176 | MP0000465_gastrointestinal_hemorrhage | 0.65241861 |
| 177 | MP0000371_diluted_coat_color | 0.63683405 |
| 178 | MP0003632_abnormal_nervous_system | 0.62740276 |
| 179 | MP0002557_abnormal_social/conspecific_i | 0.62607569 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Disinhibition (HP:0000734) | 4.51560194 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 4.19248501 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.09691474 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 3.95549908 |
| 5 | Septo-optic dysplasia (HP:0100842) | 3.94358816 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.86077524 |
| 7 | Mutism (HP:0002300) | 3.83085353 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.81864140 |
| 9 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.74426049 |
| 10 | Partial duplication of thumb phalanx (HP:0009944) | 3.71908776 |
| 11 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.71359362 |
| 12 | Abnormality of the diencephalon (HP:0010662) | 3.69112837 |
| 13 | Neonatal short-limb short stature (HP:0008921) | 3.67493951 |
| 14 | Systemic lupus erythematosus (HP:0002725) | 3.59179462 |
| 15 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.51724489 |
| 16 | Abnormal ciliary motility (HP:0012262) | 3.46467364 |
| 17 | Bronchomalacia (HP:0002780) | 3.44444311 |
| 18 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.42519835 |
| 19 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.42519835 |
| 20 | Papilledema (HP:0001085) | 3.40218757 |
| 21 | Inappropriate behavior (HP:0000719) | 3.38008324 |
| 22 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.30818117 |
| 23 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.19415939 |
| 24 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.19415939 |
| 25 | Abnormality of glycolipid metabolism (HP:0010969) | 3.19415939 |
| 26 | Esophageal atresia (HP:0002032) | 3.18838877 |
| 27 | Apathy (HP:0000741) | 3.17244202 |
| 28 | Cerebral aneurysm (HP:0004944) | 3.17198892 |
| 29 | Split foot (HP:0001839) | 3.09173590 |
| 30 | Focal motor seizures (HP:0011153) | 3.06148154 |
| 31 | Partial duplication of the phalanx of hand (HP:0009999) | 3.03177175 |
| 32 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.01606339 |
| 33 | Absent/shortened dynein arms (HP:0200106) | 3.01606339 |
| 34 | Rhinitis (HP:0012384) | 3.01177589 |
| 35 | Diminished motivation (HP:0000745) | 2.99752966 |
| 36 | Abnormality of the 4th metacarpal (HP:0010012) | 2.94697311 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 2.93965902 |
| 38 | Glomerulonephritis (HP:0000099) | 2.85717169 |
| 39 | Down-sloping shoulders (HP:0200021) | 2.82021410 |
| 40 | Absent septum pellucidum (HP:0001331) | 2.75216026 |
| 41 | Missing ribs (HP:0000921) | 2.69032280 |
| 42 | Hyperacusis (HP:0010780) | 2.67084364 |
| 43 | Anophthalmia (HP:0000528) | 2.61102808 |
| 44 | Arterial tortuosity (HP:0005116) | 2.59510039 |
| 45 | Supernumerary ribs (HP:0005815) | 2.58445135 |
| 46 | Midline defect of the nose (HP:0004122) | 2.58250899 |
| 47 | Hematochezia (HP:0002573) | 2.57392521 |
| 48 | Aplasia involving bones of the extremities (HP:0009825) | 2.57149566 |
| 49 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.57149566 |
| 50 | Aplasia of the phalanges of the hand (HP:0009802) | 2.57149566 |
| 51 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.56369905 |
| 52 | Vertebral hypoplasia (HP:0008417) | 2.56369905 |
| 53 | Subacute progressive viral hepatitis (HP:0006572) | 2.54732300 |
| 54 | Tracheomalacia (HP:0002779) | 2.54692043 |
| 55 | Gingivitis (HP:0000230) | 2.54615689 |
| 56 | Chronic bronchitis (HP:0004469) | 2.52918582 |
| 57 | Cortical dysplasia (HP:0002539) | 2.49855983 |
| 58 | Complement deficiency (HP:0004431) | 2.48384153 |
| 59 | Hemivertebrae (HP:0002937) | 2.47379212 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.47113747 |
| 61 | Striae distensae (HP:0001065) | 2.45502119 |
| 62 | Megalencephaly (HP:0001355) | 2.43064505 |
| 63 | High anterior hairline (HP:0009890) | 2.42669013 |
| 64 | Cerebral inclusion bodies (HP:0100314) | 2.42596874 |
| 65 | Neuronal loss in central nervous system (HP:0002529) | 2.42473498 |
| 66 | Trigonocephaly (HP:0000243) | 2.40451974 |
| 67 | Mucopolysacchariduria (HP:0008155) | 2.38600709 |
| 68 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.38600709 |
| 69 | Abnormality of the septum pellucidum (HP:0007375) | 2.35036303 |
| 70 | 11 pairs of ribs (HP:0000878) | 2.33485764 |
| 71 | Gastrointestinal atresia (HP:0002589) | 2.31979394 |
| 72 | Mediastinal lymphadenopathy (HP:0100721) | 2.31386774 |
| 73 | Cutaneous finger syndactyly (HP:0010554) | 2.29860554 |
| 74 | Neoplasm of the heart (HP:0100544) | 2.29597547 |
| 75 | Vitreoretinal degeneration (HP:0000655) | 2.29595794 |
| 76 | Hyperactive renin-angiotensin system (HP:0000841) | 2.28651167 |
| 77 | Vascular tortuosity (HP:0004948) | 2.27720589 |
| 78 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.26073410 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.26073410 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.26073410 |
| 81 | Myokymia (HP:0002411) | 2.23169212 |
| 82 | Neurofibrillary tangles (HP:0002185) | 2.22666322 |
| 83 | Elfin facies (HP:0004428) | 2.21855588 |
| 84 | Mitral valve prolapse (HP:0001634) | 2.21050742 |
| 85 | Abnormality of macrophages (HP:0004311) | 2.21033622 |
| 86 | Vertebral clefting (HP:0008428) | 2.20028813 |
| 87 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.19169883 |
| 88 | Axonal loss (HP:0003447) | 2.17933103 |
| 89 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.16773478 |
| 90 | Broad face (HP:0000283) | 2.16767270 |
| 91 | Coronal craniosynostosis (HP:0004440) | 2.16708888 |
| 92 | Bronchiectasis (HP:0002110) | 2.15312244 |
| 93 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.14806720 |
| 94 | Upper motor neuron abnormality (HP:0002127) | 2.14326784 |
| 95 | Maternal diabetes (HP:0009800) | 2.13515236 |
| 96 | Turricephaly (HP:0000262) | 2.13192245 |
| 97 | Bifid scrotum (HP:0000048) | 2.08404920 |
| 98 | Oligodactyly (hands) (HP:0001180) | 2.07871622 |
| 99 | Cutaneous syndactyly (HP:0012725) | 2.07487724 |
| 100 | Abnormality of complement system (HP:0005339) | 2.06915290 |
| 101 | Macroorchidism (HP:0000053) | 2.06797247 |
| 102 | Oligodactyly (HP:0012165) | 2.05070187 |
| 103 | Aortic aneurysm (HP:0004942) | 2.04841629 |
| 104 | Periodontitis (HP:0000704) | 2.04382800 |
| 105 | Absent frontal sinuses (HP:0002688) | 2.03432013 |
| 106 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.02931773 |
| 107 | Large earlobe (HP:0009748) | 2.02749506 |
| 108 | Renovascular hypertension (HP:0100817) | 2.02729268 |
| 109 | Optic nerve hypoplasia (HP:0000609) | 2.01611521 |
| 110 | Rib fusion (HP:0000902) | 1.99504514 |
| 111 | Short 4th metacarpal (HP:0010044) | 1.99349065 |
| 112 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.99349065 |
| 113 | Shallow orbits (HP:0000586) | 1.99316148 |
| 114 | Thyroid-stimulating hormone excess (HP:0002925) | 1.98411028 |
| 115 | Obstructive lung disease (HP:0006536) | 1.98240342 |
| 116 | Chronic obstructive pulmonary disease (HP:0006510) | 1.98240342 |
| 117 | Hepatoblastoma (HP:0002884) | 1.97514026 |
| 118 | Abnormality of the ischium (HP:0003174) | 1.97260035 |
| 119 | Abnormality of the parietal bone (HP:0002696) | 1.96127126 |
| 120 | Amyotrophic lateral sclerosis (HP:0007354) | 1.95092058 |
| 121 | Nephritis (HP:0000123) | 1.95049603 |
| 122 | Drooling (HP:0002307) | 1.93746869 |
| 123 | Excessive salivation (HP:0003781) | 1.93746869 |
| 124 | Lymphangioma (HP:0100764) | 1.92791275 |
| 125 | Interstitial pulmonary disease (HP:0006530) | 1.91985595 |
| 126 | Thickened helices (HP:0000391) | 1.91865401 |
| 127 | Renal hypoplasia (HP:0000089) | 1.91291991 |
| 128 | Disproportionate tall stature (HP:0001519) | 1.90871070 |
| 129 | Increased density of long bones (HP:0006392) | 1.90851220 |
| 130 | Recurrent skin infections (HP:0001581) | 1.90763843 |
| 131 | Abnormality of the dental root (HP:0006486) | 1.90529662 |
| 132 | Taurodontia (HP:0000679) | 1.90529662 |
| 133 | Abnormality of permanent molar morphology (HP:0011071) | 1.90529662 |
| 134 | Mitral stenosis (HP:0001718) | 1.90189451 |
| 135 | Overriding aorta (HP:0002623) | 1.89135852 |
| 136 | Broad metatarsal (HP:0001783) | 1.87349919 |
| 137 | Urethral obstruction (HP:0000796) | 1.85998878 |
| 138 | Amyloidosis (HP:0011034) | 1.85793412 |
| 139 | Akinesia (HP:0002304) | 1.85133440 |
| 140 | Vertebral arch anomaly (HP:0008438) | 1.85122672 |
| 141 | Chin dimple (HP:0010751) | 1.84984923 |
| 142 | Myocardial infarction (HP:0001658) | 1.81167996 |
| 143 | Bilateral microphthalmos (HP:0007633) | 1.79920376 |
| 144 | Hand muscle atrophy (HP:0009130) | 1.78491804 |
| 145 | Pointed chin (HP:0000307) | 1.77908760 |
| 146 | Diplopia (HP:0000651) | 1.77279380 |
| 147 | Abnormality of binocular vision (HP:0011514) | 1.77279380 |
| 148 | Polyphagia (HP:0002591) | 1.76709923 |
| 149 | Flattened epiphyses (HP:0003071) | 1.76475048 |
| 150 | Abnormality of molar morphology (HP:0011070) | 1.75604961 |
| 151 | Abnormality of molar (HP:0011077) | 1.75604961 |
| 152 | Insomnia (HP:0100785) | 1.75134274 |
| 153 | Recurrent sinusitis (HP:0011108) | 1.75094279 |
| 154 | Retinal atrophy (HP:0001105) | 1.75041101 |
| 155 | Arnold-Chiari malformation (HP:0002308) | 1.74303705 |
| 156 | Nasal polyposis (HP:0100582) | 1.74285731 |
| 157 | Action tremor (HP:0002345) | 1.73645234 |
| 158 | Abnormality of the dental pulp (HP:0006479) | 1.72893209 |
| 159 | Autoimmune thrombocytopenia (HP:0001973) | 1.72160372 |
| 160 | Dilatation of the ascending aorta (HP:0005111) | 1.70817270 |
| 161 | Synostosis involving the elbow (HP:0003938) | 1.69791287 |
| 162 | Humeroradial synostosis (HP:0003041) | 1.69791287 |
| 163 | Abnormality of the motor neurons (HP:0002450) | 1.69743287 |
| 164 | Abnormal neuron morphology (HP:0012757) | 1.69743287 |
| 165 | Renal dysplasia (HP:0000110) | 1.69374902 |
| 166 | Abnormality of the incisor (HP:0000676) | 1.69291795 |
| 167 | Focal seizures (HP:0007359) | 1.68868255 |
| 168 | Abnormality of the lower motor neuron (HP:0002366) | 1.68738469 |
| 169 | Synostosis of carpal bones (HP:0005048) | 1.68579378 |
| 170 | Mixed hearing impairment (HP:0000410) | 1.68565343 |
| 171 | Abnormal number of incisors (HP:0011064) | 1.67920483 |
| 172 | Abnormality of incisor morphology (HP:0011063) | 1.67531356 |
| 173 | Hypoplasia of the ulna (HP:0003022) | 1.67504670 |
| 174 | Termporal pattern (HP:0011008) | 1.67309029 |
| 175 | Insidious onset (HP:0003587) | 1.67309029 |
| 176 | Atonic seizures (HP:0010819) | 1.67047752 |
| 177 | Cellulitis (HP:0100658) | 1.66911056 |
| 178 | Dementia (HP:0000726) | 1.66298011 |
| 179 | Thin ribs (HP:0000883) | 1.66133792 |
| 180 | Bone pain (HP:0002653) | 1.65245296 |
| 181 | Omphalocele (HP:0001539) | 1.65085132 |
| 182 | Personality changes (HP:0000751) | 1.64932648 |
| 183 | Shawl scrotum (HP:0000049) | 1.64917137 |
| 184 | Myositis (HP:0100614) | 1.64413219 |
| 185 | J-shaped sella turcica (HP:0002680) | 1.64110438 |
| 186 | Lower limb asymmetry (HP:0100559) | 1.63245267 |
| 187 | Enlarged penis (HP:0000040) | 1.62949808 |
| 188 | Vacuolated lymphocytes (HP:0001922) | 1.62445288 |
| 189 | Agnosia (HP:0010524) | 1.61480799 |
| 190 | Distal upper limb amyotrophy (HP:0007149) | 1.60509901 |
| 191 | Upper limb amyotrophy (HP:0009129) | 1.60509901 |
| 192 | Postural instability (HP:0002172) | 1.60473304 |
| 193 | Frequent falls (HP:0002359) | 1.60427323 |
| 194 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.60296939 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 4.63087685 |
| 2 | PNCK | 4.02638577 |
| 3 | EPHA4 | 3.30648283 |
| 4 | CASK | 3.28539728 |
| 5 | TRIB3 | 2.83591268 |
| 6 | MAP3K9 | 2.77444871 |
| 7 | DAPK2 | 2.53896655 |
| 8 | TGFBR2 | 2.53778485 |
| 9 | RIPK4 | 2.31846891 |
| 10 | TNIK | 2.28068466 |
| 11 | PKN2 | 2.27843348 |
| 12 | EPHA3 | 2.07486307 |
| 13 | EPHA2 | 2.06195351 |
| 14 | STK38L | 2.02166581 |
| 15 | CAMK1D | 1.93889307 |
| 16 | CAMK1G | 1.92656796 |
| 17 | SIK2 | 1.86185858 |
| 18 | ERBB3 | 1.83785580 |
| 19 | CAMKK1 | 1.82395150 |
| 20 | EEF2K | 1.78078549 |
| 21 | RIPK1 | 1.75571747 |
| 22 | TSSK6 | 1.74891005 |
| 23 | NTRK2 | 1.69360925 |
| 24 | MINK1 | 1.68305742 |
| 25 | KSR1 | 1.66476914 |
| 26 | PTK6 | 1.61289974 |
| 27 | FGFR2 | 1.57835512 |
| 28 | MST1R | 1.48253393 |
| 29 | PAK6 | 1.45672401 |
| 30 | MAP3K10 | 1.44356949 |
| 31 | TBK1 | 1.40301155 |
| 32 | RPS6KA2 | 1.39753920 |
| 33 | CSF1R | 1.38190860 |
| 34 | MARK2 | 1.35216790 |
| 35 | DYRK1B | 1.29742951 |
| 36 | MATK | 1.24030429 |
| 37 | UHMK1 | 1.23256323 |
| 38 | BLK | 1.22632803 |
| 39 | KSR2 | 1.21623664 |
| 40 | BMX | 1.20847862 |
| 41 | ERN1 | 1.18961142 |
| 42 | MAP3K4 | 1.18002552 |
| 43 | JAK1 | 1.17138160 |
| 44 | DDR2 | 1.13544947 |
| 45 | CDK19 | 1.11772117 |
| 46 | SCYL2 | 1.10730923 |
| 47 | LMTK2 | 1.10527050 |
| 48 | SIK1 | 1.09537649 |
| 49 | BCR | 1.09209430 |
| 50 | NTRK1 | 1.08087911 |
| 51 | IRAK4 | 1.07027880 |
| 52 | TYRO3 | 1.06590049 |
| 53 | PHKG1 | 1.06493762 |
| 54 | PHKG2 | 1.06493762 |
| 55 | MAP3K14 | 1.05720938 |
| 56 | PAK4 | 1.05274737 |
| 57 | PLK2 | 1.03944293 |
| 58 | WEE1 | 1.03449167 |
| 59 | ALK | 0.99044562 |
| 60 | PDGFRA | 0.94924930 |
| 61 | MAP2K7 | 0.94848207 |
| 62 | TTN | 0.94512441 |
| 63 | FES | 0.94365767 |
| 64 | RET | 0.93143684 |
| 65 | EPHB2 | 0.92846544 |
| 66 | SGK223 | 0.91966275 |
| 67 | SGK494 | 0.91966275 |
| 68 | DAPK1 | 0.91304905 |
| 69 | SGK3 | 0.87048047 |
| 70 | ICK | 0.84964378 |
| 71 | LATS1 | 0.84782753 |
| 72 | LATS2 | 0.84378873 |
| 73 | KIT | 0.84033489 |
| 74 | TYK2 | 0.83248481 |
| 75 | ERBB2 | 0.82366094 |
| 76 | PRKCZ | 0.81595066 |
| 77 | NTRK3 | 0.81343731 |
| 78 | JAK2 | 0.80597328 |
| 79 | CDK6 | 0.80469165 |
| 80 | MET | 0.80153606 |
| 81 | HCK | 0.77800461 |
| 82 | STK24 | 0.77006931 |
| 83 | YES1 | 0.76808892 |
| 84 | WNK1 | 0.76464463 |
| 85 | FGR | 0.76340140 |
| 86 | CSNK1G2 | 0.76158030 |
| 87 | CDK5 | 0.71435891 |
| 88 | CHUK | 0.70484550 |
| 89 | PDGFRB | 0.69981820 |
| 90 | MAP2K4 | 0.69126936 |
| 91 | DMPK | 0.68189423 |
| 92 | FYN | 0.65800071 |
| 93 | STK11 | 0.65570875 |
| 94 | PRKD3 | 0.65179139 |
| 95 | PIK3CA | 0.63713787 |
| 96 | ROCK2 | 0.63502070 |
| 97 | PRKCG | 0.62218878 |
| 98 | MAP3K11 | 0.61134346 |
| 99 | CDK12 | 0.60883985 |
| 100 | TAOK3 | 0.60140064 |
| 101 | EGFR | 0.59817420 |
| 102 | MAPK12 | 0.59234457 |
| 103 | CAMKK2 | 0.58353909 |
| 104 | PRKCH | 0.57763379 |
| 105 | CLK1 | 0.57200782 |
| 106 | IRAK3 | 0.57087616 |
| 107 | DYRK1A | 0.56864985 |
| 108 | STK39 | 0.56239411 |
| 109 | GSK3A | 0.55658336 |
| 110 | CDK3 | 0.55527525 |
| 111 | NME1 | 0.54029157 |
| 112 | PAK2 | 0.53625930 |
| 113 | EPHB1 | 0.53542335 |
| 114 | FGFR3 | 0.53226655 |
| 115 | CSK | 0.52728634 |
| 116 | CDC42BPA | 0.51160200 |
| 117 | MTOR | 0.50866359 |
| 118 | CAMK4 | 0.50819159 |
| 119 | TESK1 | 0.49559323 |
| 120 | TAOK1 | 0.49449705 |
| 121 | MAP3K7 | 0.47875413 |
| 122 | PASK | 0.47393566 |
| 123 | CSNK1A1L | 0.47322736 |
| 124 | TGFBR1 | 0.45937637 |
| 125 | MAPK13 | 0.45642354 |
| 126 | SRC | 0.44932551 |
| 127 | SIK3 | 0.44677887 |
| 128 | CDK18 | 0.44486896 |
| 129 | SYK | 0.43797172 |
| 130 | MAP2K2 | 0.43192719 |
| 131 | SGK2 | 0.42554433 |
| 132 | CDK15 | 0.42122908 |
| 133 | FGFR4 | 0.41250953 |
| 134 | PDK1 | 0.41177535 |
| 135 | MAPK15 | 0.41149362 |
| 136 | OXSR1 | 0.39941455 |
| 137 | DYRK2 | 0.39557721 |
| 138 | CDK11A | 0.39487030 |
| 139 | ZAP70 | 0.39408867 |
| 140 | ROCK1 | 0.38819091 |
| 141 | SGK1 | 0.37480696 |
| 142 | IRAK1 | 0.37413505 |
| 143 | CAMK2B | 0.37346117 |
| 144 | PKN1 | 0.37217171 |
| 145 | MAP4K1 | 0.37204521 |
| 146 | CAMK1 | 0.35518925 |
| 147 | LRRK2 | 0.33681708 |
| 148 | CDK14 | 0.31728053 |
| 149 | WNK3 | 0.29748364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Basal cell carcinoma_Homo sapiens_hsa05217 | 2.71311080 |
| 2 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 2.58957501 |
| 3 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.20165521 |
| 4 | Histidine metabolism_Homo sapiens_hsa00340 | 2.02084173 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 1.97137970 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.96774429 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86760578 |
| 8 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.84980788 |
| 9 | * Notch signaling pathway_Homo sapiens_hsa04330 | 1.80709222 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72583757 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.69798260 |
| 12 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.67139394 |
| 13 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61797503 |
| 14 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.58698850 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.56586190 |
| 16 | Lysosome_Homo sapiens_hsa04142 | 1.56335255 |
| 17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.56005891 |
| 18 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.54954002 |
| 19 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53198381 |
| 20 | Bile secretion_Homo sapiens_hsa04976 | 1.52980436 |
| 21 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.50537257 |
| 22 | Tuberculosis_Homo sapiens_hsa05152 | 1.46872672 |
| 23 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.44099942 |
| 24 | Melanogenesis_Homo sapiens_hsa04916 | 1.42838869 |
| 25 | Pertussis_Homo sapiens_hsa05133 | 1.41985215 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.41957218 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.39263107 |
| 28 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.36944739 |
| 29 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36738768 |
| 30 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.36311734 |
| 31 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.35598948 |
| 32 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33693151 |
| 33 | Tight junction_Homo sapiens_hsa04530 | 1.32855824 |
| 34 | Glioma_Homo sapiens_hsa05214 | 1.32094890 |
| 35 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.25820371 |
| 36 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.24388293 |
| 37 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.24168141 |
| 38 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.23307165 |
| 39 | Colorectal cancer_Homo sapiens_hsa05210 | 1.22638881 |
| 40 | Phagosome_Homo sapiens_hsa04145 | 1.20596544 |
| 41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.20365838 |
| 42 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.17992749 |
| 43 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.17979487 |
| 44 | Endometrial cancer_Homo sapiens_hsa05213 | 1.17517629 |
| 45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.16852820 |
| 46 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.16342268 |
| 47 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.16337223 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.14223685 |
| 49 | Wnt signaling pathway_Homo sapiens_hsa04310 | 1.13014899 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.12869540 |
| 51 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.12439537 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.11912903 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.11840989 |
| 54 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.11734216 |
| 55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.11183011 |
| 56 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.09273755 |
| 57 | Prion diseases_Homo sapiens_hsa05020 | 1.09072184 |
| 58 | Legionellosis_Homo sapiens_hsa05134 | 1.08421953 |
| 59 | Salmonella infection_Homo sapiens_hsa05132 | 1.06894523 |
| 60 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.06529627 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.05673482 |
| 62 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.04367644 |
| 63 | Amoebiasis_Homo sapiens_hsa05146 | 1.02372665 |
| 64 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.02181706 |
| 65 | Axon guidance_Homo sapiens_hsa04360 | 1.01212309 |
| 66 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.01179412 |
| 67 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00140987 |
| 68 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98384528 |
| 69 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96765494 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.96566347 |
| 71 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.96277752 |
| 72 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96058605 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.95470138 |
| 74 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.93587193 |
| 75 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.93503725 |
| 76 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91284292 |
| 77 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.89739293 |
| 78 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.88705062 |
| 79 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.88452811 |
| 80 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.87458719 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.86568475 |
| 82 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84510313 |
| 83 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.83528819 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.83165401 |
| 85 | Olfactory transduction_Homo sapiens_hsa04740 | 0.82681868 |
| 86 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.82321758 |
| 87 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.82098034 |
| 88 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.81304395 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.80865443 |
| 90 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.80266309 |
| 91 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80008635 |
| 92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.79569905 |
| 93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.78494179 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.77383063 |
| 95 | Influenza A_Homo sapiens_hsa05164 | 0.77375012 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.77159158 |
| 97 | GABAergic synapse_Homo sapiens_hsa04727 | 0.76879683 |
| 98 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.76452831 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76445254 |
| 100 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.76326226 |
| 101 | Apoptosis_Homo sapiens_hsa04210 | 0.75830869 |
| 102 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.75708221 |
| 103 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.75217070 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.73008307 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.72951295 |
| 106 | Long-term potentiation_Homo sapiens_hsa04720 | 0.72827555 |
| 107 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72812290 |
| 108 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72649791 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.72466608 |
| 110 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.71828151 |
| 111 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.70800314 |
| 112 | Endocytosis_Homo sapiens_hsa04144 | 0.70469414 |
| 113 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.70393049 |
| 114 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.70360941 |
| 115 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.69949985 |
| 116 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.69610811 |
| 117 | Mineral absorption_Homo sapiens_hsa04978 | 0.68245899 |
| 118 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.68030156 |
| 119 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67961427 |
| 120 | Focal adhesion_Homo sapiens_hsa04510 | 0.67909717 |
| 121 | Gap junction_Homo sapiens_hsa04540 | 0.67838601 |
| 122 | Insulin resistance_Homo sapiens_hsa04931 | 0.67668266 |
| 123 | Circadian entrainment_Homo sapiens_hsa04713 | 0.66184795 |
| 124 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.66004465 |
| 125 | Salivary secretion_Homo sapiens_hsa04970 | 0.65261683 |
| 126 | Taste transduction_Homo sapiens_hsa04742 | 0.64354518 |
| 127 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64322588 |
| 128 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.64017462 |
| 129 | Asthma_Homo sapiens_hsa05310 | 0.63484637 |
| 130 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.63274267 |
| 131 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63214187 |
| 132 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.62570743 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62553244 |
| 134 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.61742620 |
| 135 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.60565895 |
| 136 | Shigellosis_Homo sapiens_hsa05131 | 0.60077329 |
| 137 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.58863770 |
| 138 | Pathways in cancer_Homo sapiens_hsa05200 | 0.58784448 |
| 139 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.58749556 |
| 140 | Malaria_Homo sapiens_hsa05144 | 0.58680367 |
| 141 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.58599262 |
| 142 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.57445058 |
| 143 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.57167392 |
| 144 | Cocaine addiction_Homo sapiens_hsa05030 | 0.56481155 |
| 145 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.56180031 |
| 146 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.55942363 |
| 147 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.55609060 |
| 148 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55488165 |
| 149 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.55145103 |
| 150 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55068015 |
| 151 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54660138 |
| 152 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.54377149 |
| 153 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.54208817 |
| 154 | Adherens junction_Homo sapiens_hsa04520 | 0.53760161 |
| 155 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.52857207 |
| 156 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52587356 |
| 157 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.50715209 |
| 158 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45728227 |
| 159 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.43742380 |
| 160 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.42855613 |
| 161 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42740657 |
| 162 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.41435553 |
| 163 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.40665338 |

